SERIO, Bianca
 Distribuzione geografica
Continente #
EU - Europa 681
NA - Nord America 414
AS - Asia 349
SA - Sud America 70
AF - Africa 3
OC - Oceania 1
Totale 1.518
Nazione #
US - Stati Uniti d'America 407
SG - Singapore 225
RU - Federazione Russa 216
IT - Italia 182
DE - Germania 134
BR - Brasile 67
FI - Finlandia 60
CN - Cina 57
IN - India 27
IE - Irlanda 24
AT - Austria 23
CZ - Repubblica Ceca 22
HK - Hong Kong 21
NL - Olanda 12
TR - Turchia 8
MX - Messico 4
SE - Svezia 3
BD - Bangladesh 2
CA - Canada 2
EC - Ecuador 2
EG - Egitto 2
FR - Francia 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
DZ - Algeria 1
ES - Italia 1
GE - Georgia 1
HR - Croazia 1
IL - Israele 1
IQ - Iraq 1
JP - Giappone 1
LK - Sri Lanka 1
MD - Moldavia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
VE - Venezuela 1
Totale 1.518
Città #
Munich 98
Ashburn 82
Singapore 81
Chandler 80
Helsinki 44
Moscow 39
Nuremberg 32
Naples 31
Princeton 27
Rome 26
Brno 22
Dublin 21
Hong Kong 18
Beijing 14
Los Angeles 12
Milan 11
Salerno 11
Amsterdam 9
Vienna 9
Washington 9
Boardman 8
Dallas 8
Lappeenranta 8
Pune 8
Seattle 8
Fisciano 7
Rio de Janeiro 6
Cava De' Tirreni 5
Domicella 5
Jyväskylä 5
Turin 5
Andover 4
Fort Worth 4
Nanjing 4
Pisa 4
São Paulo 4
Triggiano 4
West Jordan 4
Wilmington 4
Belo Horizonte 3
Curitiba 3
Guangzhou 3
Mumbai 3
Nellore 3
Piacenza 3
Rovereto 3
Santa Clara 3
Yubileyny 3
Ann Arbor 2
Arienzo 2
Atrani 2
Baoding 2
Bologna 2
Brasília 2
Cairo 2
Caprecano 2
Castel San Lorenzo 2
Castignano 2
Chennai 2
Ferrara 2
Isparta 2
Jacksonville 2
Krasnodar 2
Muğla 2
Prineville 2
Recife 2
Shanghai 2
St Petersburg 2
Tashkent 2
Toronto 2
Woodbridge 2
Ankara 1
Anápolis 1
Aracaju 1
Araçatuba 1
Auckland 1
Baghdad 1
Battipaglia 1
Bebedouro 1
Betim 1
Blumenau 1
Bordj el Kiffan 1
Bălţi 1
Camaquã 1
Cambé 1
Campinas 1
Capaccio 1
Caserta 1
Catania 1
Cayambe 1
Council Bluffs 1
Dhaka 1
Divinópolis 1
Dongguan 1
Esslingen am Neckar 1
Fairfield 1
Fuzhou 1
Genoa 1
Guapiara 1
Guaíba 1
Totale 883
Nome #
Giant plasma cells with multiple immature nuclei in a young woman with newly diagnosed multiple myeloma 167
Real-world evidence of cytomegalovirus reactivation in non-Hodgkin lymphomas treated with bendamustine-containing regimens 67
SIRT1 pharmacological activation rescues vascular dysfunction and prevents thrombosis in MTHFR deficiency 48
OPSI threat in hematological patients 46
WT1 Expression Levels Combined with Flow Cytometry Blast Counts for Risk Stratification of Acute Myeloid Leukemia and Myelodysplastic Syndromes 41
Electrophysiological Studies in Combination With Interim-Positron Emission Tomography Scan for Prevention of Severe Brentuximab-Vedotin-Induced Neurotoxicity 38
Post-Transplant Cyclophosphamide (PTCY) as GVHD Prophylaxis for Hematopoietic Stem Cell Transplantation From Matched-Related Sibling Donors 37
Lenalidomide-induced psoriasis in a refractory multiple myeloma patient successfully treated with narrowband ultraviolet B 34
Reduced Proliferative Potential with Conserved Stem/Stromal Phenotype of Human Umbilical Cord Mesenchymal Stem Cells in Placental Syndromes: A Prospective Cohort Study 33
Letermovir Prophylaxis For Cytomegalovirus Reactivation in Allogeneic Stem Cell Transplantation: A Multicenter Italian Real-world Experience 32
Non-invasive prenatal test identifies circulating cell-free DNA chromosomal abnormalities derived from clonal hematopoiesis in aggressive hematological malignancies 31
Hemopoiesis and Immune Cell Perturbations during Venetoclax Plus Azacytidine Treatment in Acute Myeloid Leukemia 31
Letermovir Prophylaxis for Cytomegalovirus Infection in Allogeneic Stem Cell Transplantation: A Real-World Experience 31
Inter-intra instrument comparison and standardization of a 10-color immunophenotyping for B and T cell non-Hodgkin lymphoma diagnosis and monitoring 29
Implementation of International Prognostic Index with flow cytometry immunophenotyping for better risk stratification of chronic lymphocytic leukemia 28
Kaposi's sarcoma associated with chronic myeloid leukemia and imatinib mesylate therapy 28
Efficacy of Decitabine and Venetoclax as Salvage and Bridge Therapy to Haploidentical Hematopoietic Stem Cell Transplantation in a Multiresistant Acute Myeloid Leukemia Patient 27
Low-Density Granulocytes Are Decreased in Acute Myeloid Leukemia and in Myelodysplastic Syndromes with Negative Prognostic Factors 27
SERUM FREE LIGHT CHAIN RATIO AS A BIOMARKER OF MULTIPLE MYELOMA PROGRESSION AND ASSOCIATED RENAL DISEASE 27
Persistent decreased bone marrow CD3+CD56+ T lymphocytes are inversely associated with mature granulocytes in myelodysplastic syndromes 27
Cytomegalovirus reactivation is frequent in multiple myeloma patients treated with daratumumab-based regimens 26
A Frail Hairy Cell Leukemia Patient Successfully Treated with Pegylated Interferon-α-2A 26
Efficacy and safety of belantamab-mafodotin in triple-refractory multiple myeloma patients: A multicentric real-life experience 26
Clinical efficacy of azacytidine and venetoclax and prognostic impact of Tim-3 and galectin-9 in acute myeloid leukemia and high-risk myelodysplastic syndromes: A single-center real-life experience 26
Serum Free Light-Chain Ratio at Diagnosis Is Associated with Early Renal Damage in Multiple Myeloma: A Case Series Real-World Study 25
c-Kit M541L variant is related to ineffective hemopoiesis predisposing to clonal evolution in 3D in vitro biomimetic co-culture model of bone marrow niche 25
INTENSIFICATION AND MAINTENANCE WITH RITUXIMAB IN PATIENTS WITH DLBCL IN UNCERTAIN CR OR PR (PET-ORIENTED) AFTER INDUCTION THERAPY WITH R-CHOP OR SIMILAR THERAPIES; OUR EXPERIENCE 23
Multiple myeloma characteristics correlated to serum free light chain ratio at diagnosis and association with early renal damage 23
All Roads Lead to Interferon-γ: From Known to Untraveled Pathways in Acquired Aplastic Anemia 23
INCREASE OF BONE EVENTS (FRACTURES) IN PATIENTS WITH AGGRESSIVE NON-HODGKIN LYMPHOMA: NEGATIVE SYNERGISM BETWEEN STEROIDS AND LOW MOLECULAR WEIGHT HEPARIN (LMWH)? OUR EXPERIENCE 22
Biomimetic proteolipid vesicles for reverting GPI deficiency in paroxysmal nocturnal hemoglobinuria 22
Effective Neutralizing Antibody Response Against SARS-CoV-2 Virus and Its Omicron BA.1 Variant in Fully Vaccinated Hematological Patients 21
Clinical Efficacy of Isatuximab Plus Carfilzomib and Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients 21
Artificial Intelligence in Hypertension Management: An Ace up Your Sleeve 21
Limited efficacy of 3 + 7 plus gemtuzumab ozogamycin in newly diagnosed fit intermediate genetic risk acute myeloid leukemia patients 21
Hodgkin Lymphoma and Hairy Cell Leukemia Arising from Chronic Lymphocytic Leukemia: Case Reports and Literature Review 21
Antimicrobial Susceptibility Profiles of Klebsiella pneumoniae Strains Collected from Clinical Samples in a Hospital in Southern Italy 21
Contribution of peripheral blood mononuclear cells isolated by advanced filtration system to myogenesis of human bone marrow mesenchymal stem cells co-cultured with myoblasts 21
DECREASED LOW-DENSITY GRANULOCYTES AS POSSIBLE DIAGNOSTIC MARKERS OF MYELODYSPLASTIC SYNDROMES WITH EXCESS OF BLASTS 20
An economic evaluation of fine-needle cytology as the primary diagnostic tool in the diagnosis of lymphadenopathy 20
Biclonality in hairy cell leukemia: Co-occurrence of CD10+ and CD10− clones with different surface membrane immunoglobulin expression 20
BONE MARROW MESENCHYMAL STEM CELLS AS FACILITATOR OF RUXOLITINIB-MEDIATED INHIBITION OF JAK2 MUTADED CELLS 20
The Current and Future Impact of Lymph Node Fine-Needle Aspiration Cytology on Patient Care 19
null 19
Actinomycosis mimicking malignancy: a report of three cases diagnosed with fine-needle aspiration cytology 19
Transient Daratumumab-Induced Refractive Shift in Multidrug-Resistant Multiple Myeloma: Case Report and Literature Review 19
Subclones with variants of uncertain clinical significance might contribute to ineffective hemopoiesis and leukemia predisposition 19
Clinical Utility of TRBC1 Addition in Multiparametric Flow Cytometry for T Cell Lymphoma Diagnosis 19
Safety of Subcutaneous Daratumumab in Anti-CD38 Monoclonal Antibody-Naïve Patients with Plasma Cell Disorders: A Multicenter Real-Life Experience 18
Post-Transplant Cyclophosphamide versus Anti-Thymocyte Globulin in Patients with Hematological Malignancies Treated with Allogeneic Hematopoietic Stem Cell Transplantation from Haploidentical and Matched Unrelated Donors: A Real-Life Experience 17
A Rare Immune-Related Mesenteric and retroperitoneal serositis in a Multi-Refractory Hodgkin Lymphoma Patient Successfully Treated with Chylolymphostatic Surgery 16
Macrophages and Urokinase Plasminogen Activator Receptor System in Multiple Myeloma: Case Series and Literature Review 16
Cytopathological differential diagnosis of malignant tumor cells in the cerebrospinal fluid: A retrospective analysis 15
Innovative Anti-CD38 and Anti-BCMA Targeted Therapies in Multiple Myeloma: Mechanisms of Action and Resistance 15
Efficacy of Daratumumab-Based Regimens for Extramedullary Pulmonary Plasmacytoma: A Case Report 14
ELTROMBOPAG IS AN EFFECTIVE TREATMENT OF POOR GRAFT FUNCTION AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: A GITMO SURVEY 12
Combined fine needle aspiration cytology and core needle biopsy in the same setting: A two-years' experience 10
Immunological derangement in hypocellular myelodysplastic syndromes 9
Sex, Age, and Previous Herpes Zoster Infection Role on Adverse Events Following Immunization with Adjuvanted Recombinant Vaccine 6
Oxidative Stress in Atopic Dermatitis and Possible Biomarkers: Present and Future 6
Impact of minimal residual disease response and of status of disease on survival after blinatumomab in B-cell acute lymphoblastic leukemia: results from a real-life study 4
Secretory and Membrane-Associated Biomarkers of Mast Cell Activation and Proliferation 1
Totale 1.596
Categoria #
all - tutte 10.516
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.516


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202125 0 0 0 0 0 0 0 0 0 7 14 4
2021/202251 3 0 0 10 3 1 0 2 2 1 3 26
2022/2023205 10 23 14 20 11 34 14 22 33 0 16 8
2023/2024392 35 29 30 29 34 53 35 23 10 17 27 70
2024/2025923 31 22 17 40 58 102 301 94 202 53 3 0
Totale 1.596